Sumitomo Pharma Co., Ltd. (TYO:4506)
1,811.00
+173.00 (10.56%)
Sep 5, 2025, 3:30 PM JST
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 719.49 billion as of September 5, 2025. Its market cap has increased by 269.59% in one year.
Market Cap
719.49B
Enterprise Value
1.01T
Revenue
416.16B
Ranking
n/a
PE Ratio
38.06
Stock Price
1,811.00
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 719.49B, an increase of 249.39%. That is a compound annual growth rate of 3.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 719.49B | 221.67% |
Dec 30, 2024 | 223.67B | 20.82% |
Dec 29, 2023 | 185.14B | -53.35% |
Dec 30, 2022 | 396.90B | -24.60% |
Dec 30, 2021 | 526.41B | -13.00% |
Dec 30, 2020 | 605.08B | -28.50% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 10.89T |
Takeda Pharmaceutical Company | 7,144.56B |
HOYA Corporation | 7,022.35B |
Daiichi Sankyo Company | 6,702.26B |
Otsuka Holdings | 4,357.61B |
Terumo | 3,902.25B |
Astellas Pharma | 3,045.32B |
Shionogi & | 2,267.87B |